Ghany MG, Strader DB, Thomas DL, Seeff LB. American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49(4):1335–74.
Article
CAS
PubMed
Google Scholar
Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology (Baltimore, Md). 2013;57(4):1333–42.
Article
Google Scholar
Breban R, Doss W, Esmat G, Elsayed M, Hellard M, Ayscue P, Albert M, Fontanet A, Mohamed MK. Towards realistic estimates of HCV incidence in Egypt. J Viral Hepat. 2013;20(4):294–6.
Article
CAS
PubMed
Google Scholar
Manns MP, Foster GR, Rockstroh JK, Zeuzem S, Zoulim F, Houghton M. The way forward in HCV treatment--finding the right path. Nat Rev Drug Discov. 2007;6(12):991–1000.
Article
CAS
PubMed
Google Scholar
Coligan JE, Vogel S. Innate Immunity. In: Coligan JE, Bierer BE, Margulies DH, Shevach EM, Strober W, editors. Current Protocols in Immunology. Hoboken: Wiley; 2012. p. 1401–7.
Google Scholar
Landi A, Yu H, Babiuk LA, van Drunen Littel-van den Hurk S. Human dendritic cells expressing hepatitis C virus core protein display transcriptional and functional changes consistent with maturation. J Viral Hepat. 2011;18(10):700–13.
Article
CAS
PubMed
Google Scholar
Wang JH, Layden TJ, Eckels DD. Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response. Hum Immunol. 2003;64(7):662–73.
Article
CAS
PubMed
Google Scholar
Kaplan DE. Immunopathogenesis of Hepatitis C Virus Infection. Gastroenterol Clin North Am. 2015;44(4):735–60. doi:10.1016/j.gtc.2015.07.004.
Article
PubMed
Google Scholar
Foy E, Li K, Wang C, Sumpter Jr R, Ikeda M, Lemon SM, Gale Jr M. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science. 2003;300(5622):1145–8.
Article
CAS
PubMed
Google Scholar
Ivanovska N, Philipov S. Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions, and pure alkaloids. Int Immunopharmacol. 1996;18:552–61.
Google Scholar
Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res. 2008;2(8):999–1012.
Article
Google Scholar
Kim T, kang B, Cho D, Kim S. Induction of interleukin-12 in mouse macrophage by berberine, a benzodioxoloquinolizine, deviates CD4+ T cells from Th2 to Th1 response. Immunology. 2003;109:407–14.
Article
CAS
PubMed
PubMed Central
Google Scholar
Aziz M, Ghareeb D, Eweda S, Hussien H, El Demellawy M. Immunomodulatory effect of Berberis vulgaris extracts on murine splenocytes and enrichment of dendritic cells in vitro. Biotechnol Biotechnol Equip. 2015;29(6):1149–55.
Article
Google Scholar
Abd El-Wahab A, Ghareeb D, Sarhan E, Abu-Serie M, El Demellawy M. In vitro Biological and Therapeutic Effects of Berberis vulgaris and its Active Constituent, Berberine: Antioxidants, cholinergic, anti-diabetic and anticancer effects. BMC Complement. Altern Med. 2013;13:218.
Google Scholar
Ghareeb D, Abd El-Wahab AE, Sarhan EEM, Marwa M, Abu-Serie MM, El Demellawy MA. Biological assessment of Berberis vulgaris and its active constituent, berberine: Antibacterial, antifungal and anti-hepatitis C virus (HCV) effect. J Medicinal Plants Research. 2013;7(21):1529–36.
Google Scholar
National Health and Medical Research Council. Guidelines to promote the wellbeing of animals used for scientific purposes : the assessment and alleviation of pain and distress in research animals. 2008:1–189. doi:10.1037/e513122012-001.
Sakai Y, Morrison BJ, Burke JD, Park JM, Terabe M, Janik JE, Forni G, Berzofsky JA, Morris JC. Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents. Cancer Res. 2004;64(21):8022–8.
Article
CAS
PubMed
Google Scholar
Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162(1):156–9.
Article
CAS
PubMed
Google Scholar
Lazdina U, Hultgren C, Frelin L, Chen M, Lodin K, Weiland O, Leroux-Roels G, Quiroga JA, Peterson DL, Milich DR, Sällberg M. Humoral and CD4 (+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein. J Gen Virol. 2001;82(6):1299–308.
Article
CAS
PubMed
Google Scholar
Nimmerjahn F, Ravetch JV. Fc gamma receptors as regulators of immune responses. Nat Rev Immunol. 2008;8(1):34–47.
Article
CAS
PubMed
Google Scholar
de Baey A, Mende I, Riethmueller G, Baeuerle PA. Phenotype and function of human dendritic cells derived from M-DC8 (+) monocytes. Eur J Immunol. 2001;6:1646–55.
Article
Google Scholar
Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767–811.
Article
CAS
PubMed
Google Scholar
Spear TT, Riley TP, Lyons GE, et al. Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instability. J Leukoc Biol. 2016: doi:10.1189/jlb.2A1215-561R.
Zhao L, Tyrrell DL. Myeloid dendritic cells can kill T cells during chronic hepatitis C virus infection. Viral Immunol. 2013;26(1):25–39.
Article
CAS
PubMed
Google Scholar
Rosenberg S. Recent advances in the molecular biology of hepatitis C virus. J Mol Biol. 2001;313(3):451–64.
Article
CAS
PubMed
Google Scholar
Kao CC, Yi G, Huang H. The core of hepatitis C virus pathogenesis. Curr Opin Virol. 2016;17:66–73.
Article
CAS
PubMed
Google Scholar
Clarke B. Molecular virology of hepatitis C virus. J Gen Virol. 1997;78(10):2397–410.
Article
CAS
PubMed
Google Scholar
Saito K, Meyer K, Warner R, Basu A, Ray RB, Ray R. Hepatitis C Virus Core Protein Inhibits Tumor Necrosis Factor Alpha-Mediated Apoptosis by a Protective Effect Involving Cellular FLICE Inhibitory Protein. J Virol. 2006;80(9):4372–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hu X, Zimmerman MA, Bardhan K, Yang D, Waller JL, Liles GB, Lee JR, Pollock R, Lev D, Ware CF, Garber E, Bailly V, Browning JL, Liu K. Lymphotoxin β receptor mediates caspase-dependent tumor cell apoptosis in vitro and tumor suppression in vivo despite induction of NF-kB activation. Carcinogenesis. 2013;34(5):1105–14.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pavio N, Lai MM. The hepatitis C virus persistence: how to evade the immune system? J Biosci. 2003;28(3):287–304.
Article
CAS
PubMed
Google Scholar
Larrubia JR, Moreno-Cubero E, Miquel J, Sanz-de-Villalobos E. Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control. World J Gastroenterol. 2015;21(12):3480–91.
Article
CAS
PubMed
PubMed Central
Google Scholar
Valiante NM, D’Andrea A, Crotta S, Lechner F, Klenerman P, Nuti S, Wack A, Abrignani S. Life, activation and death of intrahepatic lymphocytes in chronic hepatitis C. Immunol Rev. 2000;174:77–89.
Article
CAS
PubMed
Google Scholar
Bain C, Fatmi A, Zoulim F, Zarski JP, Trépo C, Inchauspé G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology. 2001;120(2):512–4.
Article
CAS
PubMed
Google Scholar
Auffermann-Gretzinger S, Keeffe EB, Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood. 2001;97(10):3171–6.
Article
CAS
PubMed
Google Scholar
Malta FM, Bruno FR, Carvalho KI, Nastri AC, Kalil J, Carrilho FJ, et al. HCV viremia drives an increment of CD86 expression by myeloid dendritic cells. J Med Virol. 2013;85(11):1919–24.
Article
CAS
PubMed
Google Scholar
Zhu HH, Xu KL, Pan XY, Liu JQ, Chen FX, Huang YH. Specific anti-leukemic cell effect mediated by dendritic cells pulsed with chronic myelogenous leukemia lysate antigen in vitro. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003;11(3):278–81.
PubMed
Google Scholar
Berhanu A, Huang J, Alber SM, Watkins SC, Storkus WJ. Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8 (+) T-cell cross-priming but is ineffective as a therapy. Cancer Res. 2006;66(9):4895–903.
Article
CAS
PubMed
Google Scholar
Randolph GJ, Sanchez-Schmitz G, Liebman RM, Schäkel k. The CD16+ (FcγRIII+) Subset of Human Monocytes Preferentially Becomes Migratory Dendritic Cells in a Model Tissue Setting. J Exp Med. 2002;196(4):517–27.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mende I, Hoffmann P, Wolf A, Lutterbüse R, Kopp E, Baeuerle PA, de Baey A, Kufer P. Highly efficient antigen targeting to M-DC8+ dendritic cells via FcgammaRIII/CD16-specific antibody conjugates. Int Immunol. 2005;17(5):539–47.
Article
CAS
PubMed
Google Scholar
Haverson K, Singha S, Stokes CR, Bailey M. Professional and non-professional antigen-presenting cells in the porcine small intestine. Immunology. 2000;101(4):492–500.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu H, Rhodes M, Wiest DL, Vignali DA. On the dynamics of TCR:CD3 complex cell surface expression and down modulation. Immunity. 2000;13(5):665–75.
Article
CAS
PubMed
Google Scholar
Dolganiuc A, Chang S, Kodys K, Mandrekar P, Bakis G, Cormier M, Szabo G. Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J Immunol. 2006;177(10):6758–68.
Article
CAS
PubMed
Google Scholar
Stone AEL, Mitchell A, Brownell J, et al. Hepatitis C virus core protein inhibits interferon production by a human plasmacytoid dendritic cell line and dysregulates interferon regulatory factor-7 and signal transducer and activator of transcription (STAT) 1 protein expression. PLoS One. 2014;9(5):e95627.
Article
PubMed
PubMed Central
Google Scholar
Bacchetta R, Gregori S, Roncarolo MG. CD4+ regulatory T cells: mechanisms of induction and effector function. Autoimmun Rev. 2005;4(8):491–6.
Article
PubMed
Google Scholar
Yamane H, Paul WE. Early signaling events that underlie fate decisions of naive CD4 (+) T cells toward distinct T-helper cell subsets. Immunol Rev. 2013;252(1):12–23.
Article
PubMed
PubMed Central
Google Scholar
MacQuillan GC, Mamotte C, Reed WD, Jeffrey GP, Allan JE. Upregulation of endogenous intrahepatic interferon stimulated genes during chronic hepatitis C virus infection. J Med Virol. 2003;70(2):219–27.
Article
CAS
PubMed
Google Scholar
Trinchieri G. Immunobiology of interleukin-12. Immunol Res. 1998;17(2):269–78.
Article
CAS
PubMed
Google Scholar
Schurich A, Pallett LJ, Lubowiecki M, et al. The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells. PLoS Pathog. 2013;9(3):e1003208.
Article
CAS
PubMed
PubMed Central
Google Scholar
Spanakis NE, Garinis GA, Alexopoulos EC, et al. Cytokine serum levels in patients with chronic HCV infection. J Clin Lab Anal. 2002;16(1):40–6.
Article
CAS
PubMed
Google Scholar
Reiser M, Marousis CG, Nelson DR, Lauer G, González-Peralta RP, Davis GL, Lau JY. Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection. J Hepatol. 1997;26(3):471–8.
Article
CAS
PubMed
Google Scholar
Saraiva M, O’Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol. 2010;10(3):170–81.
Article
CAS
PubMed
Google Scholar
Akdis CA, Akdis M. Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs. J Clin Invest. 2014;124(11):4678–80.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gigi E, Raptopoulou-Gigi M, Kalogeridis A, Masiou S, Orphanou E, Vrettou E, Lalla TH, Sinakos E, Tsapas V. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease. J Viral Hepat. 2008;2:145–54.
Google Scholar
Jiang C, Magee DM, Cox RA. Construction of a single-chain interleukin-12-expressing retroviral vector and its application in cytokine gene therapy against experimental coccidioidomycosis. Infect Immun. 1999;67(6):2996–3001.
CAS
PubMed
PubMed Central
Google Scholar
Hamza T, Barnett JB, Li B. Interleukin 12 a key immunoregulatory cytokine in infection applications. Int J Mol Sci. 2010;11(3):789–806.
Article
CAS
PubMed
PubMed Central
Google Scholar
Roozendaal R, Vellenga E, Postma DS, De Monchy JGR, Kauffman HF. Nitric oxide selectively decreases interferonγ expression by activated human T lymphocytes via a cGMP‐independent mechanism. Immunol. 1999;98(3):393–9.
Article
CAS
Google Scholar